To study the use of oral zinc tablet in reducing sore throat after general anaesthesia in patients undergoing surgeries
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/04/041800
- Lead Sponsor
- Dr Lisana Latheef
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
patients posted for elective low and moderate risks surgeries of duration less than or equal to 30 minutes to less than or equal to 2 hours under general anaesthesia of ASA PS grade I and II
patients refusal to consent , patients with pregnancy, altered coagulation profile or bleeding diathesis, smokers , recent history of sore throat or upper respiratory tract infection, mallampatti grade III or more, allergic to zinc, body mass index of 35 or greater, increased risk of aspiration such as gastro esophageal reflux disease, trauma to airway, alcoholism, drug abuse, psychological or other emotional problems that are likely to invalidate the informed consent or limit the ability of the subject to comply with the protocol requirements will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence and severity of post operative sore throat is studied using verbal rating scale 0 to 3, o equals to no sore throat, 1 equals to mild sore throat on questioning, 2 equals to moderate degree of sore throat complaints of his or her own, 3 equals to severe sore throat change in voice, hoarseness and throat painTimepoint: Immediate post operative period , 2hours, 4hours, and 24hours post operative respectively
- Secondary Outcome Measures
Name Time Method The incidence of cough and restlessness during post operative periodTimepoint: Immediate post operative period, 2hours, 4hours and 24hours post operatively